Tomography News and Research

RSS

Omeros announces positive data from OMS824 Phase 1 clinical trial

Omeros Corporation today announced positive data from the Company's Phase 1 clinical trial evaluating the pharmacokinetics of OMS824, the lead compound in Omeros' phosphodiesterase 10 program, further supporting that OMS824 can achieve superior target engagement with lesser side effects compared to other PDE10 inhibitors in development.

12 Sep 2013

GGO-dominant lung tumors have excellent prognosis

Ground glass opacity-dominant clinical stage IA lung adenocarcinoma is a low-grade malignancy with an “excellent” prognosis, Japanese researchers believe.

10 Sep 2013

Banook Central Imaging, Oncodesign partner to expand use of new approaches in pharmaco-imaging

Oncodesign, a contract research laboratory dedicated to the discovery of new anticancer therapies, and Banook Central Imaging, a company specializing in the centralized reading of medical images, today announce the start of a partnership to expand the use of new approaches in pharmaco-imaging.

10 Sep 2013

Engineers develop network of wireless sensors that can detect person falling

University of Utah electrical engineers have developed a network of wireless sensors that can detect a person falling. This monitoring technology could be linked to a service that would call emergency help for the elderly without requiring them to wear monitoring devices.

10 Sep 2013

MRI: A valuable tool for assessing risk of heart attack, stroke in diabetic patients

Whole-body MRI may serve as a valuable noninvasive tool for assessing the risk of heart attack and stroke in diabetic patients, according to a new study published online in the journal Radiology.

10 Sep 2013

Bronchial thermoplasty effective in long term

Researchers have shown that the asthma-control benefits of bronchial thermoplasty remain for as long as 5 years following treatment.

9 Sep 2013

Combined screening could boost COPD detection

Researchers from Japan say that the detection of chronic obstructive pulmonary disease could be enhanced by incorporating screening into existing lung cancer screening programs.

6 Sep 2013

CT screening proven effective for lung cancer

There is strong evidence to support the effectiveness of screening for lung cancer with low-dose computed tomography, a systematic review has found.

5 Sep 2013

PET imaging predicts favorable outcome after decompressive surgery in patients with cervical myelopathy

For patients with degenerative cervical myelopathy, imaging with 18F-FDG positron emission tomography (PET) could act as a marker for a potentially reversible phase of the disease in which substantial clinical improvement can be achieved.

5 Sep 2013

Ontario researchers develop evidence-based recommendations for lung cancer screening

Lung cancer is the most common cause of cancer death in Ontario. Screening for lung cancer using low-dose computed tomography has been the subject of many research studies since the 1990s. The National Lung Screening Trial compared LDCT with chest radiograph in high-risk populations and found a 20 percent reduction in lung cancer mortality at 6 years with LDCT after an initial scan and two annual rounds of screening.

5 Sep 2013

Researchers find new form of imaging technology to diagnose different types of cancer

Researchers from University Hospitals Case Medical Center have published findings that a new form of imaging -- PET/MRI -- is promising for several types of cancer.

30 Aug 2013

Patient-relevant benefit of PET or PET/CT in oesophageal cancer is still unclear

The patient-relevant benefit of positron emission tomography (PET) in oesophageal cancer, alone or in combination with computed tomography (CT), is not proven due to a lack of comparative studies. In terms of their diagnostic and prognostic accuracy, it also remains unclear whether these diagnostic techniques can detect the spreading of tumours better than conventional diagnostics.

29 Aug 2013

Tumor vessel density linked to mRCC treatment response

Changes in tumor vessel density correlate with response and resistance to anti-angiogenic therapy in patients with metastatic renal cell carcinoma, study findings suggest.

28 Aug 2013

Muscle density improves mRCC prognosis prediction

Patients with metastatic renal cell carcinoma treated with targeted therapies have a better prognosis if they also have a high quality of muscle, study findings indicate.

28 Aug 2013

Alzheimer’s drug trial: an interview with Geoffrey Kempler, Chairman & CEO Prana Biotechnology

Approval for the IMAGINE trial was granted by the Austin Health Research Ethics Committee in November 2011, with the first patients dosed in March the following year. However, well before the trial was approved, PBT2 had already shown promise in significantly changing Abeta levels in spinal fluid while improving cognition in a previous 12-week trial conducted in 2006.

28 Aug 2013

Navidea Biopharmaceuticals signs SPA agreements with FDA for NAV5001 Phase 3 program

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that it has reached agreement with the U.S. Food and Drug Administration for two special protocol assessments for the Company's pivotal Phase 3 program with NAV5001 as an aid in the differential diagnosis of Parkinsonian Syndromes from non-Parkinsonian tremor.

23 Aug 2013

Study shows continuous CSF drainage is associated with complications in patients with SAH

Researchers at Duke University conducted a randomized clinical trial in patients with subarachnoid hemorrhage (SAH). In this study, the researchers compared two approaches to intracranial pressure management-continuous and intermittent drainage of cerebrospinal fluid (CSF)-and outcomes associated with those methods, focusing specifically on the incidence of cerebral vasospasm.

21 Aug 2013

Medical response, imaging technologies used to save lives of Boston Marathon bombing victims

The Boston Marathon bombing brought international attention back to the devastating effects of terrorism. There were numerous victims with severe injuries that needed immediate attention. A novel study in Arthritis Care & Research, a journal published by Wiley on behalf of the American College of Rheumatology, presents cases from Boston-area hospitals where victims were treated, examining the medical response and imaging technologies used to save lives and limbs.

20 Aug 2013

ASH announces 12 recipients of its second round of ASH Bridge Grants

As federal funding cuts continue to jeopardize the progress of biomedical research, the American Society of Hematology (ASH), the world's largest professional organization dedicated to the causes and treatments of blood disorders, today announced the 12 recipients of its second round of ASH Bridge Grants.

16 Aug 2013

Neuroimaging specialists use tanners to identify whether UV light triggers brain's pleasure sensors

Neuroimaging specialists at UT Southwestern Medical Center are launching the first clinical trial involving frequent and infrequent tanners designed to identify whether UV light triggers the brain's pleasure sensors.

13 Aug 2013

Tomography News and Research

Omeros announces positive data from OMS824 Phase 1 clinical trial

GGO-dominant lung tumors have excellent prognosis

Banook Central Imaging, Oncodesign partner to expand use of new approaches in pharmaco-imaging

Engineers develop network of wireless sensors that can detect person falling

MRI: A valuable tool for assessing risk of heart attack, stroke in diabetic patients

Bronchial thermoplasty effective in long term

Combined screening could boost COPD detection

CT screening proven effective for lung cancer

PET imaging predicts favorable outcome after decompressive surgery in patients with cervical myelopathy

Ontario researchers develop evidence-based recommendations for lung cancer screening

Researchers find new form of imaging technology to diagnose different types of cancer

Patient-relevant benefit of PET or PET/CT in oesophageal cancer is still unclear

Tumor vessel density linked to mRCC treatment response

Muscle density improves mRCC prognosis prediction

Alzheimer’s drug trial: an interview with Geoffrey Kempler, Chairman & CEO Prana Biotechnology

Navidea Biopharmaceuticals signs SPA agreements with FDA for NAV5001 Phase 3 program

Study shows continuous CSF drainage is associated with complications in patients with SAH

Medical response, imaging technologies used to save lives of Boston Marathon bombing victims

ASH announces 12 recipients of its second round of ASH Bridge Grants

Neuroimaging specialists use tanners to identify whether UV light triggers brain's pleasure sensors

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News